Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…
December 29, 2008 · Posted in Daily Health News · Comment
IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Latisse (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes
December 8, 2008 · Posted in Daily Health News · Comment
IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve Latisse…
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts